Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
149 Leser
Artikel bewerten:
(0)

EQS-News: CMB International: Union Medical Healthcare at Attractive Valuation

Dow Jones received a payment from EQS/DGAP to publish this press release.

EQS-News / 30/10/2017 / 07:00 UTC+8 
 
*[FOR IMMEDIATE RELEASE] 
/* 
 
*CMB International: Union Medical Healthcare at Attractive Valuation * 
*Diversified Business Segments to Facilitate Cross-selling 
Prudent Expansion to Foster Long-term Development* 
 
(27 October 2017, Hong Kong) CMB International issued a research report, 
pointed out that *Union Medical Healthcare Limited* ("Union Medical 
Healthcare" or the "Company"; together with its subsidiaries, the "Group", 
SEHK stock code: 2138), as the largest aesthetic medical service provider in 
Hong Kong, the Group recorded a strong growth in revenue in FY2017, with a 
better profitability and ROE over peers. Management guided that the net 
profit growth rate will be in line with revenue growth rate in FY18/FY19, 
which is expected to be above 20%. The valuation of the Group is attractive 
in view of its better growth rate in revenue and net profit. 
 
According to CMB International, the Group has taken a more prudent approach 
on expansion, which would be an adoptable strategy for long-term 
development. The full time registered practitioners increased from 23 in 
FY2016 to 44 in FY2017. The average utilization rate of its Hong Kong 
clinics has already reached its optimal rate of 60%-70%. The Group has 
planned to establish 1-2 aesthetic medical clinics each year in first and 
second tier cities in China and prefers forming joint ventures with local 
established aesthetic medical players with customer base and licenses. 
 
Furthermore, CMB International indicated that medical tourism has become a 
major growth driver for the Group. In FY2017, revenue from PRC clients was 
HK$241.2 million and accounted for 25% of total revenue, representing a 
Y-o-Y growth of 9 percentage points. Of which 92% came from medical tourists 
in Hong Kong. The Group has its in-house travel agent in cope of growing 
demand of medical tourists. Besides, the PRC clinics also refer clients to 
Hong Kong. The Group expected the proportion of revenue from PRC clients to 
increase to 30%-40% in FY2018. 
 
*Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of 
Union Medical Healthcare* said, "Union Medical Healthcare has been 
dedicating in expanding our scope of services for diversity. The Group's 
cross-selling capabilities has been proven from the synergistic effect that 
was being created. Our outstanding sales performance is a testimony to our 
insightful operative strategies of offering one-stop medical, health and 
beauty services. We will continue to capture market opportunities actively 
whilst adopting a prudent expansion strategy, as to strengthen the Group's 
leading position in the market for aesthetic medical services to generate 
better returns for our investors." 
 
- End - 
 
*About Union Medical Healthcare Limited* 
Union Medical Healthcare is principally engaged in the provision of one-stop 
aesthetic medical, beauty and health management solutions with 46 clinics 
and servicing centres across Hong Kong, the PRC and Macao as at 30 September 
2017. In 2016, the Group obtained the Hong Kong Top Service Brand and opened 
re:HEALTH, a one-stop health management centre, to provide a full range of 
services and products, including comprehensive health screening, health 
product and health management services. The Group is the largest aesthetic 
medical service provider in Hong Kong in terms of revenue. The Group ranked 
first in Hong Kong from 2012 to 2016 in terms of the number of aesthetic 
injection procedures performed involving utilization of the top-six 
revenue-generating aesthetic medications in Hong Kong; and was the Black 
Diamond Provider of the transparent orthodontic device for teeth alignment, 
Invisalign(R), in 2015 and 2016. The Group has successfully built DR REBORN, 
a well-recognized brand in Hong Kong, with the reputation of being a premier 
provider of aesthetic medical services in Hong Kong. 
 
*For further information, please contact: 
iPR Ogilvy & Mather* 
Callis Lau / Molisa Lau / Maggie Chui / Francesca Yeung 
Tel: (852) 2136 6952 / 2136 6953 / 2136 8059 / 3920 7639 
Fax: (852) 3170 6606 
Email: umh@iprogilvy.com 
 
30/10/2017 Dissemination of a Financial Press Release, transmitted by EQS 
Group. 
The issuer is solely responsible for the content of this announcement. 
 
Media archive at www.todayir.com 
 

(END) Dow Jones Newswires

October 29, 2017 19:02 ET (23:02 GMT)

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.